IGF2BP3 and colorectal adenocarcinoma: Although prior investigators have assessed a group of colorectal adenocarcinomas for the presence of IGF2BP3 protein via IHC [15–17], a quantitative analysis of these tumors for IGF2BP3 mRNA expression in a sizable population of patients has not yet been carried out.